Literature DB >> 4156295

Studies of the fate of metabolites and analogs of probenecid. The significance of metabolic sites, especially lack of ring hydroxylation.

P G Dayton, J M Perel, R F Cunningham, Z H Israili, I M Weiner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4156295

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  7 in total

1.  Non-linear elimination and protein binding of probenecid.

Authors:  B M Emanuelsson; B Beermann; L K Paalzow
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Quantitation of CSF concentrations and biological activity of probenecid metabolites.

Authors:  B E Roos; G Wickström; P Hartvig; J L Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1980       Impact factor: 2.953

3.  Interindividual variation in the capacity-limited renal glucuronidation of probenecid by humans.

Authors:  T B Vree; E W Van Ewijk-Beneken Kolmer; E W Wuis; Y A Hekster; M M Broekman
Journal:  Pharm World Sci       Date:  1993-10-15

4.  Capacity-limited renal glucuronidation of probenecid by humans. A pilot Vmax-finding study.

Authors:  T B Vree; E W Van Ewijk-Beneken Kolmer; E W Wuis; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1992-10-16

5.  Metabolism and clearance of proxicromil--studies in rat, hamster, rabbit, dog, squirrel monkey, cynomolgus monkey, baboon and man.

Authors:  D A Smith; M G Neale
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Jul-Sep       Impact factor: 2.441

Review 6.  Clinical pharmacokinetics of probenecid.

Authors:  R F Cunningham; Z H Israili; P G Dayton
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

7.  In vitro Metabolism of Bumetanide.

Authors:  G Grosa; F Viola; O Caputo; G Biglino
Journal:  Pharm Res       Date:  1984-11       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.